Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
1 raison identifiée
Auteur de référence en rhumatologie
30 articles scientifiques publiés — un praticien à la pointe de la recherche
✨ Génération du profil synthétique IA en cours…
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
The American journal of sports medicine · 2017
Background: Intra-articular normal saline (IA-NS) injections have been utilized as a placebo in a number of randomized controlled trials pertaining to the management of knee osteoarthritis (OA); however, it is believed that these “placebo” injections may have a therapeutic effect that has not been quantified in the literature. Purpose: To (1) quantify the effect of IA-NS injections on patient-reported outcomes (PROs) and (2) compare postinjection PROs to established minimal clinically important difference (MCID) criteria to demonstrate a potential therapeutic effect. Study Design: Meta-analysis. Methods: A review was conducted to identify all randomized, placebo-controlled trials on injection therapy for knee OA between 2006 and 2016. Patient demographics and PROs before the injection and at 3 and 6 months after the injection were collected for patients in the IA-NS injection group in each study. A random-effects model was used to compare preinjection scores and scores at each postinjection time point in a pairwise fashion. Results: In total, there were 14 placebo cohorts in 13 studies that were analyzed after meeting inclusion criteria for this meta-analysis. This included 1076 patients (Kellgren-Lawrence grade 1-4), with a weighted mean age of 62.53 years and mean body mass index of 28.67 kg/m 2 . There was only sufficient information to perform analyses of visual analog scale (VAS) pain and Western Ontario and McMaster Universities Arthritis Index (WOMAC) total scores. At 3 months after the IA-NS placebo injection, there was a significant improvement in VAS pain scores (mean difference [MD], 12.10 [95% CI, 3.27 to 20.93]; P = .007), whereas improvement in the WOMAC total scores approached but did not reach statistical significance (MD, 19.75 [95% CI, –0.50 to 40.09]; P = .06). At 6 months, both VAS pain scores (MD, 16.62 [95% CI, 12.13-21.10]; P < .00001) and WOMAC total scores (MD, 11.34 [95% CI, 7.03-15.65]; P < .00001) were significantly improved in comparison to preinjection values. Furthermore, improvements in both the VAS pain and WOMAC total scores at 6 months were clinically significant (MCID, 1.37 and 9, respectively). Conclusion: The administration of an IA-NS placebo injection yields a statistically and clinically meaningful improvement in PROs up to 6 months after the injection in patients with knee OA. This observation supports the notion that the so-called placebo effect for IA-NS injections achieves a clinically meaningful response in patients with OA when provided during comparison studies to an active treatment group (ie, hyaluronic acid).
JMIR mHealth and uHealth · 2019
Background Chronic rheumatic diseases need long-term treatment and professional supervision. Mobile apps promise to improve the lives of patients and physicians. In routine practice, however, rheumatology apps are largely unknown and little is known about their quality and safety. Objective The aim of this study was to provide an overview of mobile rheumatology apps currently available in German app stores, evaluate app quality using the Mobile Application Rating Scale (MARS), and compile brief, ready-to-use descriptions for patients and rheumatologists. Methods The German App Store and Google Play store were systematically searched to identify German rheumatology mobile apps for patient and physician use. MARS was used to independently assess app quality by 8 physicians, 4 using Android and 4 using iOS smartphones. Apps were randomly assigned so that 4 apps were rated by all raters and the remaining apps were rated by two Android and two iOS users. Furthermore, brief app descriptions including app developers, app categories, and features were compiled to inform potential users and developers. Results In total, 128 and 63 apps were identified in the German Google Play and App Store, respectively. After removing duplicates and only including apps that were available in both stores, 28 apps remained. Sixteen apps met the inclusion criteria, which were (1) German language, (2) availability in both app stores, (3) targeting patients or physicians as users, and (4) clearly including rheumatology or rheumatic diseases as subject matter. Exclusion criteria were (1) congress apps and (2) company apps with advertisements. Nine apps addressed patients and 7 apps addressed physicians. No clinical studies to support the effectiveness and safety of apps could be found. Pharmaceutical companies were the main developers of two apps. Rheuma Auszeit was the only app mainly developed by a patient organization. This app had the highest overall MARS score (4.19/5). Three out of 9 patient apps featured validated questionnaires. The median overall MARS score was 3.85/5, ranging from 2.81/5 to 4.19/5. One patient-targeted and one physician-targeted app had MARS scores >4/5. No significant rater gender or platform (iOS/Android) differences could be observed. The overall correlation between app store ratings and MARS scores was low and inconsistent between platforms. Conclusions To our knowledge, this is the first study that systematically identified and evaluated mobile apps in rheumatology for patients and physicians available in German app stores. We found a lack of supporting clinical studies, use of validated questionnaires, and involvement of academic developers. Overall app quality was heterogeneous. To create high-quality apps, closer cooperation led by patients and physicians is vital.
Kidney international · 2016
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Health services insights · 2024 · Journal Article
Grischott T, Mehra T, Meyer MR, Senn O, et al.
Zeitschrift fur Rheumatologie · 2023 · English Abstract
Holzapfel DE, Thieme M, Kappenschneider T, Holzapfel S, et al.
American journal of clinical pathology · 2022 · Journal Article
Skaugen JM, Sayre C, Hassett AC, Chibisov I, et al.
RMD open · 2021 · Journal Article
Kernder A, Morf H, Klemm P, Vossen D, et al.
Zeitschrift fur Rheumatologie · 2019 · Journal Article
Knitza J, Vossen D, Geffken I, Krusche M, et al.
Scandinavian journal of rheumatology · 2019 · Journal Article
Meyer MK, Andersen M, Ring T, Andersen GN, et al.
American journal of clinical pathology · 2017 · Journal Article
Seheult JN, Meyer MP, Bontempo FA, Chibisov I
Orthopaedic journal of sports medicine · 2017 · Journal Article
Meyer MA, Leroux TS, Levy DM, Tilton AK, et al.
Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association · 2016 · Journal Article
Makhni EC, Meyer MA, Saltzman BM, Cole BJ
The journal of knee surgery · 2016 · Journal Article
Waddell BS, Zahoor T, Meyer M, Ochsner L, et al.
Arthritis & rheumatology (Hoboken, N.J.) · 2014 · Journal Article
Toh ML, Bonnefoy JY, Accart N, Cochin S, et al.
Joint bone spine · 2012 · Journal Article
Elhai M, Paternotte S, Burki V, Durnez A, et al.
Stem cell research & therapy · 2024 · Journal Article
Ali EAM, Smaida R, Meyer M, Ou W, et al.
International journal of rheumatic diseases · 2021 · Journal Article
Meyer MM, Marks LA, Aslam F
JMIR mHealth and uHealth · 2019 · Journal Article
Knitza J, Tascilar K, Messner EM, Meyer M, et al.
Clinical and experimental rheumatology · 2023 · Case Reports
Vial G, Gensous N, Meyer M, Duffau P
Clinical and experimental immunology · 2017 · Journal Article
Kluger MA, Nosko A, Ramcke T, Goerke B, et al.
Kidney international · 2016 · Journal Article
Kluger MA, Melderis S, Nosko A, Goerke B, et al.
Journal of clinical medicine · 2024 · Journal Article
Reinhard J, Michalk K, Schiegl JS, Pagano S, et al.
The Journal of arthroplasty · 2024 · Journal Article
Meyer M, Leiß F, Götz JS, Holzapfel DE, et al.
Annals of the rheumatic diseases · 2013 · Letter
Sellam J, Kotti S, Fellahi S, Bastard JP, et al.
Arthritis research & therapy · 2013 · Journal Article
Meyer M, Sellam J, Fellahi S, Kotti S, et al.
International journal of rheumatic diseases · 2021 · Journal Article
Meyer MM, Marks LA, Aslam F
The American journal of sports medicine · 2017 · Journal Article
Saltzman BM, Leroux T, Meyer MA, Basques BA, et al.
Clinical and experimental immunology · 2017 · Journal Article
Kluger MA, Nosko A, Ramcke T, Goerke B, et al.
Journal of the South African Veterinary Association · 2014 · Journal Article
Aitchison H, Poolman P, Coetzer M, Griffiths C, et al.
Journal of personalized medicine · 2024 · Journal Article
Stensballe A, Andersen JS, Aboo C, Andersen AB, et al.
Schmerz (Berlin, Germany) · 2021 · Journal Article
Al-Qadi M, Renaud D, Meyer M
Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology · 2023 · Journal Article
Pagano S, Holzapfel S, Kappenschneider T, Meyer M, et al.
Clinical and experimental rheumatology · 2013 · Journal Article
Chauffier K, Paternotte S, Burki V, Durnez A, et al.
140609-e012-53.z01
140609-e012-53.z05
140609-e012-53.z03
Untersuchung der algebraischen Integrirbarkeit der linearen homogenen Differentialgleichungen vierter Ordnung mit Hilfe von Differentialinvarianten
Kosmographisches Skizzenbuch : die Forschungen unserer Zeit über die Einrichtung des Weltgebäudes
https://creativecommons.org/publicdomain/mark/1.0/
Glückwunschblätter
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).
World neurosurgery · 2018 · Case Reports
Boissonneau S, Graillon T, Meyer M, Brunel H, et al.
Journal of clinical medicine · 2021 · Journal Article
Leiss F, Götz JS, Maderbacher G, Meyer M, et al.